PortfoliosLab logoPortfoliosLab logo
SURI vs. FTXH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

SURI vs. FTXH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simplify Propel Opportunities ETF (SURI) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SURI vs. FTXH - Yearly Performance Comparison


2026 (YTD)202520242023
SURI
Simplify Propel Opportunities ETF
-2.66%28.32%-13.34%-2.87%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
4.48%24.15%2.98%-0.99%

Returns By Period

In the year-to-date period, SURI achieves a -2.66% return, which is significantly lower than FTXH's 4.48% return.


SURI

1D
2.27%
1M
-6.14%
YTD
-2.66%
6M
8.30%
1Y
19.80%
3Y*
7.84%
5Y*
10Y*

FTXH

1D
2.61%
1M
-3.36%
YTD
4.48%
6M
21.14%
1Y
26.79%
3Y*
11.30%
5Y*
7.36%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SURI vs. FTXH - Expense Ratio Comparison

SURI has a 2.51% expense ratio, which is higher than FTXH's 0.60% expense ratio.


Return for Risk

SURI vs. FTXH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURI
SURI Risk / Return Rank: 4040
Overall Rank
SURI Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
SURI Sortino Ratio Rank: 4343
Sortino Ratio Rank
SURI Omega Ratio Rank: 3838
Omega Ratio Rank
SURI Calmar Ratio Rank: 3939
Calmar Ratio Rank
SURI Martin Ratio Rank: 3636
Martin Ratio Rank

FTXH
FTXH Risk / Return Rank: 6868
Overall Rank
FTXH Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 7171
Sortino Ratio Rank
FTXH Omega Ratio Rank: 6565
Omega Ratio Rank
FTXH Calmar Ratio Rank: 7575
Calmar Ratio Rank
FTXH Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURI vs. FTXH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify Propel Opportunities ETF (SURI) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SURIFTXHDifference

Sharpe ratio

Return per unit of total volatility

0.76

1.28

-0.52

Sortino ratio

Return per unit of downside risk

1.19

1.78

-0.59

Omega ratio

Gain probability vs. loss probability

1.15

1.24

-0.09

Calmar ratio

Return relative to maximum drawdown

0.99

1.95

-0.96

Martin ratio

Return relative to average drawdown

3.33

5.94

-2.61

SURI vs. FTXH - Sharpe Ratio Comparison

The current SURI Sharpe Ratio is 0.76, which is lower than the FTXH Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of SURI and FTXH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SURIFTXHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.76

1.28

-0.52

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

0.06

0.38

-0.32

Correlation

The correlation between SURI and FTXH is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

SURI vs. FTXH - Dividend Comparison

SURI's dividend yield for the trailing twelve months is around 17.49%, more than FTXH's 1.23% yield.


TTM2025202420232022202120202019201820172016
SURI
Simplify Propel Opportunities ETF
17.49%16.31%21.41%14.71%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.23%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%

Drawdowns

SURI vs. FTXH - Drawdown Comparison

The maximum SURI drawdown since its inception was -47.76%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for SURI and FTXH.


Loading graphics...

Drawdown Indicators


SURIFTXHDifference

Max Drawdown

Largest peak-to-trough decline

-47.76%

-32.11%

-15.65%

Max Drawdown (1Y)

Largest decline over 1 year

-16.94%

-12.74%

-4.20%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

Current Drawdown

Current decline from peak

-24.28%

-3.36%

-20.92%

Average Drawdown

Average peak-to-trough decline

-17.42%

-5.88%

-11.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.18%

4.68%

+0.50%

Volatility

SURI vs. FTXH - Volatility Comparison

Simplify Propel Opportunities ETF (SURI) has a higher volatility of 7.04% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 6.24%. This indicates that SURI's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SURIFTXHDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.04%

6.24%

+0.80%

Volatility (6M)

Calculated over the trailing 6-month period

16.73%

12.06%

+4.67%

Volatility (1Y)

Calculated over the trailing 1-year period

26.36%

21.10%

+5.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.62%

16.15%

+12.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.62%

18.45%

+10.17%